These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8997693)

  • 1. Studies of antibiotic resistance of rough and smooth Proteus mirabilis strains and influence of polymyxin E on their lipopolysaccharide composition.
    Kaca W; Ujazda E
    Acta Microbiol Pol; 1996; 45(2):161-8. PubMed ID: 8997693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells.
    Arabski M; Wasik S; Dworecki K; Kaca W
    J Microbiol Methods; 2009 May; 77(2):178-83. PubMed ID: 19318050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
    Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
    Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
    Kaca W; Radziejewska-Lebrecht J; Bhat UR
    Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
    Kaca W; Literacka E; Sjöholm AG; Weintraub A
    J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of some biological activities of lipopolysaccharides obtained from smooth and rough Proteus mirabilis strains.
    Klink M; Brzychcy M; Ziółkowski A; Swierzko A; Sułowska Z; Cedzyński M; Tchórzewski H
    Acta Microbiol Pol; 1998; 47(2):141-51. PubMed ID: 9839373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharide part of Proteus mirabilis lipopolysaccharide may be responsible for the stimulation of platelet adhesion to collagen.
    Zielinski T; Wachowicz B; Saluk-Juszczak J; Kaca W
    Platelets; 2002 Nov; 13(7):419-24. PubMed ID: 12487790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion of thrombin-stimulated and unstimulated blood platelets to collagen in the presence of Proteus mirabilis lipopolysaccharides.
    Saluk-Juszczak J; Wachowicz B; Zielinski T; Kaca W
    Platelets; 2001 Dec; 12(8):470-5. PubMed ID: 11798396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of Proteus hauseri bacteria to chemotherapeutic preparations depending on the cultivation conditions and on the composition of the nutrient medium].
    Shvidenko IG
    Antibiotiki; 1977 May; 22(5):440-4. PubMed ID: 327915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple drug resistance in Klebsiella-Enterobacter, Proteus mirabilis and Pseudomonas aeruginosa--an analysis of all-nation computer-processed data.
    Grunt J; Krcméry V
    Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):105-12. PubMed ID: 826047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to antibiotics of Proteus strains from various sources].
    Korneva EP; Baĭramova AS; Iakh'eva SA; Slutskiĭ VI; Danevich MV
    Antibiotiki; 1984 Apr; 29(4):263-71. PubMed ID: 6378079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
    McCoy AJ; Liu H; Falla TJ; Gunn JS
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2030-7. PubMed ID: 11408219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The properties of chitosan complexes with smooth and rough forms of lipopolysaccharides on CHO-K1 cells.
    Arabski M; Lisowska H; Lankoff A; Davydova VN; Drulis-Kawa Z; Augustyniak D; Yermak IM; Molinaro A; Kaca W
    Carbohydr Polym; 2013 Sep; 97(2):284-92. PubMed ID: 23911447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial modification of LPS and resistance to antimicrobial peptides.
    Gunn JS
    J Endotoxin Res; 2001; 7(1):57-62. PubMed ID: 11521084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergism of colistin and trimethoprim against Proteus bacteria in vivo].
    Freiesleben H
    Int J Clin Pharmacol; 1972 Aug; 6(3):285-90. PubMed ID: 4567539
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
    Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro effect of cephacetril and colistin combinations on Klebsiella pneumoniae and Proteus Strains (author's transl)].
    Daschner F
    Arzneimittelforschung; 1976; 26(1):87-9. PubMed ID: 779799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core region in Proteus mirabilis lipopolysaccharide.
    Kotełko K; Gromska W; Papierz M; Sidorczyk Z; Krajewska D; Szer K
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):271-84. PubMed ID: 342599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
    Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
    Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.